Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation

被引:28
|
作者
Seo, Ji-Weon [1 ]
Kim, Hyun Kyung [1 ,2 ]
Kim, Ji-Eun [1 ,2 ]
Park, Seonyang [3 ]
Cho, Han-Ik [1 ]
机构
[1] Seoul Natl Univ, Dept Lab Med, Coll Med, Seoul 110744, South Korea
[2] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul 110744, South Korea
[3] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul 110744, South Korea
关键词
Disseminated intravascular coagulation; Procoagulant phospholipids; Factor Xa-activated clotting time; Thrombin-antithrombin complex; Endogenous thrombin potential; CRITICALLY-ILL PATIENTS; PLATELET MICROPARTICLES; SCORING SYSTEM; INTERNATIONAL SOCIETY; HEMOSTASIS; GENERATION; DIAGNOSIS; SEPSIS; PLASMA; RATIO;
D O I
10.1016/j.thromres.2008.03.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Widespread coagulation activation and intravascular fibrin formation are clinical features of disseminated intravascular coagulation (DIC). The endogenous thrombin potential (ETP) has been shown to be a useful marker for hypo- or hypercoagulability. The factor Xa-activated clotting time (XACT) represents plasma levels of procoagulant phospholipids. We investigated whether the ETP and XACT would be good prognostic markers in patients suspected of having DIC and whether these markers would show a significant correlation with the thrombin-antithrombin complex (TAT), a marker of in vivo coagulation activation. Methods: One hundred twenty-nine patients suspected of having DIC were enrolled for the study. The TAT was measured by ELISA. The ETP and XACT were measured by calibrated automated thrombinography. The 28-day mortality was used as a predictor of clinical outcomes. Results: In overt DIC, higher XACT (9.67 vs. 7.33 min) and higher TAT (26.15 vs. 11.56 ng/ml) results were obtained from the nonsurvivors than from the survivors.ETP levels were tower in the overt DIC group than in the no overt DIC group. In receiver operating characteristic analysis, which was conducted to predict the 28-day mortality, the areas under the receiver operating characteristic analysis curve were as follows: 0.71 (95% CI: 0.62-0.78) for the XACT, 0.70 (0.61-0.77) for the TAT, and 0.64 (0.55-0.72) for the ETP. For the diagnosis of overt DIC, the area under the curve of XACT, TAT and ETP were 0.77 (0.69-0.84), 0.64 (0.55-0.72) and 0.73 (0.64-0.80), respectively. The odds ratio of the XACT for the relative risk of 28-day mortality was 9.60 (3.53-26.11), and that of the TAT was 5.18 (2.11-12.72) and that of the ETP 7.66 (1.67-35.17). For the diagnosis of overt DIC, the odds ratio of XACT, TAT and ETP were 37.35 (4.86-286.89), 4.89 (1.93-12.43) and 4.89 (1.98-12.09), respectively. There was a negative correlation between the TAT and ETP (r=-0.223, P=0.012) and a positive correlation between the TAT and XACT (r=0.251, P=0.004). Conclusion: Our results suggest that the XACT and ETP may be useful diagnostic and prognostic markers for the DIC. Among various markers, the XACT serves as a good prediction of the 28-day mortality in patients suspected of having DIC. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:565 / 572
页数:8
相关论文
共 37 条
  • [1] Prognostic value of platelet indices as determined by ADVIA 120 in patients suspected of having disseminated intravascular coagulation
    Kim, H. K.
    Kim, J. -E.
    Ham, C. K.
    Lee, D. S.
    Park, S.
    Cho, H. -I.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 (02) : 117 - 123
  • [2] Factor Xa-activated whole blood clotting time (Xa-ACT) for bedside monitoring of dalteparin anticoagulation during haemodialysis
    Frank, RD
    Brandenburg, VM
    Lanzmich, R
    Floege, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (06) : 1552 - 1558
  • [3] LEVELS OF ACTIVATED FACTOR-VII IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION
    SAITO, M
    ASAKURA, H
    YOSHIDA, T
    JOKAJI, H
    UOTANI, C
    KUMABASHIRI, I
    MORISHITA, E
    YAMAZAKI, M
    AOSHIMA, K
    MATSUDA, T
    BLOOD, 1995, 85 (12) : 3770 - 3771
  • [4] Measurement of whole blood factor Xa-activated clotting time during hemodialysis with low-molecular-weight heparin
    Mori M.
    Yoshitake S.
    Kitano T.
    Oda S.
    Noguchi T.
    Journal of Anesthesia, 1998, 12 (3) : 130 - 132
  • [5] ANTI-THROMBIN-III (AT) IN CRITICALLY ILL PATIENTS WITH CLINICALLY SUSPECTED DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
    TRAN, TH
    LAMMLE, B
    DUCKERT, F
    THROMBOSIS AND HAEMOSTASIS, 1983, 50 (01) : 291 - 291
  • [6] Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation
    Sallah, S
    Husain, A
    Nguyen, NP
    BLOOD COAGULATION & FIBRINOLYSIS, 2004, 15 (07) : 577 - 582
  • [7] TIME SEQUENCE OF COAGULATION DATA IN PATIENTS WITH DECOMPENSATED LIVER-CIRRHOSIS AND SUSPECTED DISSEMINATED INTRAVASCULAR COAGULATION
    CIONI, G
    CRISTANI, A
    TINCANI, E
    VENTURA, P
    ZAGNI, G
    VENTURA, E
    RESEARCH IN CLINIC AND LABORATORY, 1991, 21 (01): : 105 - 109
  • [8] Diagnostic and Prognostic Value of Plasma Factor V Activity and Parameters in Thrombin Generation for Disseminated Intravascular Coagulation in Patients with Hematological Malignancies
    Kou, Hai-ming
    Zhang, Xiao-ping
    Wang, Man-zhi
    Deng, Jun
    Mei, Meng
    Hu, Yu
    CURRENT MEDICAL SCIENCE, 2019, 39 (04) : 546 - 550
  • [9] Diagnostic and Prognostic Value of Plasma Factor V Activity and Parameters in Thrombin Generation for Disseminated Intravascular Coagulation in Patients with Hematological Malignancies
    Hai-ming Kou
    Xiao-ping Zhang
    Man-zhi Wang
    Jun Deng
    Heng Mei
    Yu Hu
    Current Medical Science, 2019, 39 : 546 - 550
  • [10] Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation
    Gando, S
    Nanzaki, S
    Sasaki, S
    Kemmotsu, O
    THROMBOSIS AND HAEMOSTASIS, 1998, 79 (06) : 1111 - 1115